港股異動丨紅星美凱龍(01528.HK)午後炒起 大幅拉昇漲超7%
格隆匯5月25日丨紅星美凱龍(1528.HK)午後股價現直線拉昇上漲行情,現報4.87港元創2個月新高價,漲7.51%,總市值超190億港元。近日紅星美凱龍推進員工持股計劃為公司賦能,加速“輕資產、重運營”轉型。事實上,早在2019年上半年,紅星美凱龍控股股東及附屬企業之部分員工已經在籌劃購買上市公司股份。分析人士指出,紅星美凱龍控股股東及附屬企業之部分員工購買上市公司股份計劃再加碼,以及員工持股計劃有序推進,二者並行,充分彰顯了多方對公司未來持續穩定發展的信心,也是為企業發展賦能的有效方式。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.